Real-time enrollment status for this cancer clinical trial
Current Status
Recruiting
Checked: July 14, 2026 at 1:24 PM UTC
| NCT Number | NCT06907043 |
| Recruiting Status | Recruiting |
| Condition | Cancer |
| Phase | PHASE1 |
| Target Enrollment | 130 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Eikon Therapeutics |
| Last Updated on CT.gov | August 19, 2025 (Aug 19, 2025) |
As of July 14, 2026: Clinical trial NCT06907043 is currently recruiting participants. This phase1 study for cancer is actively seeking new participants at 6 locations across the United States. The study is sponsored by Eikon Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06907043 is actively recruiting participants as of July 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06907043 was last updated Aug 19, 2025 (August 19, 2025). HelloStudys verifies this status automatically.